MyFinsight
Home
Blog
About
Net income
$22,121K
(22.22%↑ Y/Y)
Accounts receivable
-$6,247K
(-293.64%↓ Y/Y)
Depreciation and
amortization
$5,808K
(-46.00%↓ Y/Y)
Share-based compensation
expense
$2,932K
(-65.15%↓ Y/Y)
Accrued compensation
$2,300K
(-19.69%↓ Y/Y)
Provision for losses on
accounts receivable
$1,782K
(-6.41%↓ Y/Y)
Other current assets
-$766K
(-120.47%↓ Y/Y)
Other
-$118K
(72.56%↑ Y/Y)
Net cash provided by
operating activities
$30,025K
(-19.90%↓ Y/Y)
Canceled cashflow
$12,049K
Net change in cash
and cash...
$24,914K
(75.98%↑ Y/Y)
Canceled cashflow
$5,111K
Other operating
liabilities
-$8,518K
(-107.65%↓ Y/Y)
Inventories
$3,283K
(32.59%↑ Y/Y)
Accounts payable
-$248K
(-106.61%↓ Y/Y)
Other
$581K
(20.54%↑ Y/Y)
Contingent liability
payments related to...
-$2,059K
(-205.59%↓ Y/Y)
Contributions
fromnon-controllinginterests
$574K
(-53.30%↓ Y/Y)
Other
-$187K
(-138.80%↓ Y/Y)
Net cash used in
investing activities
-$4,306K
(76.79%↑ Y/Y)
Net cash used in
financing activities
-$805K
(83.16%↑ Y/Y)
Canceled cashflow
$581K
Canceled cashflow
$2,820K
Purchases of property and
equipment
$4,618K
(-54.33%↓ Y/Y)
something is missing
-$2,259K
something is missing
-$269K
Principal payments on
finance lease...
$1,039K
(-54.35%↓ Y/Y)
Distributions
tonon-controllinginterests
$327K
(73.02%↑ Y/Y)
Back
Back
Cash Flow
Guardian Pharmacy Services, Inc. (GRDN)
Guardian Pharmacy Services, Inc. (GRDN)
source: myfinsight.com